90. 網膜色素変性症 Retinitis pigmentosa Clinical trials / Disease details

臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02609165 (ClinicalTrials.gov)	May 2015	12/10/2015	Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Ed ...	Nerve Growth Factor Eye Drops as a Novel Treatment for Vision Loss in Patients With Retinitis Pigmen ...	Retinitis Pigmentosa;Cystoid Macular Edema	Drug: rhNGF 180 µg/ml eye drops solution;Drug: vehicle eye drops	Ospedale San Raffaele	Dompé Farmaceutici S.p.A	Completed	18 Years	N/A	All	45	Phase 2	Italy
2	EUCTR2014-000385-22-IT (EUCTR)	07/10/2014	12/05/2014	Nerve Growth Factor eye drops as a novel treatment for patients with Retinitis Pigmentosa.	Nerve Growth Factor eye drops as a novel treatment for vision loss in patients with Retinitis Pigmen ...	Retinitis pigmentosa with cystoid macular edema MedDRA version: 17.0;Level: LLT;Classification code ...	Product Name: recombinant human Nerve Growth Factor (rhNGF) INN or Proposed INN: not yet assigned Othe ...	Ospedale San Raffaele di Milano	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Italy
3	NCT02110225 (ClinicalTrials.gov)	January 2014	8/4/2014	A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGFin Patients With Retiniti ...	A 24 Week Phase Ib/II, Multicenter, Randomized, Controlled, Parallel Group, Dose Ranging Study With ...	Retinitis Pigmentosa	Drug: rhNGF 60 µg/ml eye drops solution;Drug: rhNGF 180 µg/ml eye drops solution;Drug: Placebo	Dompé Farmaceutici S.p.A	NULL	Completed	18 Years	N/A	All	50	Phase 1/Phase 2	Italy

First Previous1Next Last